Dextroamphetamine, commonly prescribed for the treatment of ADHD and narcolepsy, represents a potent central nervous system agent with a complex pharmacological profile. Knowing its mode of operation – primarily impacting dopamine and norepinephrine neurotransmission – is careful consideration due to potential adverse reactions and the risk of